This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
AT Europe 2019: Roundtable Information
Share |

The Roundtable session will be a truly interactive workshop to connect and discuss real issues with your peers. These sessions were designed to be informal (but structured) discussions on topics which are of interest to participants. Participation will be on a first come, first serve basis. Each topic will include a facilitator, whose role is to help assist the discussion and ensure a lively exchange, and a scribe, whose role is to make general, anonymous notes about the discussion. Notes will be posted on this page two weeks after the conference. See below for a list of this year's topics.

Table 1: Analytical Challenges and Solutions of Therapeutics Beyond mAbs
Facilitator: Andras Guttman, Northeastern University
Scribe: Markus Haindl, F. Hoffman - La Roche Ltd. 
Abstract and Notes

Table 2: Analytical Method Life Cycle Management and the Revised ICH Q2 and New ICH Q14
Facilitator: Christoph Finkler, F. Hoffman - La Roche Ltd. 
Scribe: Elena Dominguez-Vega, Leiden University
Abstract and Notes

Table 3: Development of Chromatographic Methods - The New and the Old
Facilitator: Balazs Bobaly, Solvias
Scribe: Birgit Schmauser, BfArM, Federal Institute for Drugs and Medical Devices
Abstract

Table 4: HCP Testing Strategies
Facilitator: Annemiek Verwilligen, Janssen, Infectious Diseases and Vaccines
Scribe: Carsten Jahn, AbbVie, Inc.
Abstract and Notes

Table 5: MS-based Methods in the QC Lab - What is the State of the Art?
Facilitator: Pierre Allemand, Protein Metrics Inc.
Scribe: Arjen Scholten, Janssen Vaccines and Prevention
Abstract and Notes

Table 6: New CE-based Methods in the QC Lab - What Are the Challenges and Learnings?
Facilitator: Friederike Junge, AbbVie Deutschland GmbH & Co KG 
Scribe: Debbie van der Burg, Kantisto BV
Abstract and Notes

Table 7: PAT
Facilitator: Marta Germano, Janssen, Infectious Diseases and Vaccines
Scribe: Tom Branson, Janssen, Infectious Diseases and Vaccines
Abstract and Notes

Table 8: Physio-chemical Methods to Replace Bioassays for Potency and Biological Activity Testing - Examples and Experience
Facilitator: Harold Taylor, Merz Pharmaceuticals GmbH
Scribe: Jérôme Thiebaud, Sanofi
Abstract and Notes

Table 9: What is the State of the Art Regarding Methods for Analysis of Glycans and Glycoproteins?
Facilitator: Simone Albrecht, Pfizer, Inc.
Scribe: Kasia Kozakowska, MedImmune, A member of the AstraZeneca Group
Abstract and Notes

Table 10: Hot Topic
Facilitator: Cari Sänger – van de Griend,  Kantisto BV
Scribe: Joel Welch, CDER, FDA
Notes


 

 

Membership Software Powered by YourMembership  ::  Legal